Clinical Trial

A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease

Study acronym: eMPOWER
Recruiting
View on ClinicalTrials.gov →
Summary
The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-22
Trial Details
NCT Number NCT07382349
Lead Sponsor Vanderbilt University Medical Center
Collaborators: American Association for the Study of Liver Diseases
Conditions MASLD
Enrollment 7,200 participants
Start Date 2026-07-20
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-21